Seasonal Allergic Rhinitis - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Seasonal Allergic Rhinitis - Pipeline Review, H2 2016

Seasonal Allergic Rhinitis - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Seasonal Allergic Rhinitis - Pipeline Review, H2 2016
Published Aug 17, 2016
49 pages — Published Aug 17, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Seasonal Allergic Rhinitis - Pipeline Review, H2 2016, provides an overview of the Seasonal Allergic Rhinitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Seasonal Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Seasonal Allergic Rhinitis and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Seasonal Allergic Rhinitis
- The report reviews pipeline therapeutics for Seasonal Allergic Rhinitis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Seasonal Allergic Rhinitis therapeutics and enlists all their major and minor projects
- The report assesses Seasonal Allergic Rhinitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Seasonal Allergic Rhinitis

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Seasonal Allergic Rhinitis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipe

  
Source:
Document ID
GMDHC8364IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Seasonal Allergic Rhinitis Overview61
Therapeutics Development71
  Pipeline Products for Seasonal Allergic Rhinitis Overview71
Seasonal Allergic Rhinitis Therapeutics under Development by Companies81
Seasonal Allergic Rhinitis Pipeline Products Glance92
  Late Stage Products91
  Clinical Stage Products101
Seasonal Allergic Rhinitis Products under Development by Companies111
Seasonal Allergic Rhinitis Companies Involved in Therapeutics Development128
  Allergy Therapeutics Plc121
  Faes Farma, S.A.131
  Glenmark Pharmaceuticals Ltd.141
  Hisamitsu Pharmaceutical Co., Inc.151
  Merck &Co., Inc.161
  Pfizer Inc.171
  Shionogi &Co., Ltd.181
  VentiRx Pharmaceuticals, Inc.191
Seasonal Allergic Rhinitis Therapeutics Assessment209
  Assessment by Monotherapy Products201
  Assessment by Target212
  Assessment by Mechanism of Action232
  Assessment by Route of Administration252
  Assessment by Molecule Type272
Drug Profiles2914
  asapiprant Drug Profile291
  bilastine Drug Profile302
  desloratadine Drug Profile322
  emedastine difumarate Drug Profile341
  GSP-301 Drug Profile351
  PF-06444752 Drug Profile362
  PF-06444753 Drug Profile382
  Pollinex Quattro Tree Drug Profile402
  VTX-1463 Drug Profile421
Seasonal Allergic Rhinitis Dormant Projects432
Seasonal Allergic Rhinitis Discontinued Products451
Seasonal Allergic Rhinitis Product Development Milestones462
  Featured News &Press Releases461
    May 09, 2016: Allergy Therapeutics Announces Positive Top-Line Results From the PQBirch204 Phase II Study for Birch-Induced Seasonal Allergic Rhinitis461
    Apr 25, 2016: Aralez Receives Health Canada Approval For BLEXTEN461
    Oct 11, 2013: FDA Approves Sanofi's Nasacort Allergy 24HR for Over-the-Counter Use471
Appendix482
  Methodology481
  Coverage481
  Secondary Research481
  Primary Research481
  Expert Panel Validation481
  Contact Us481
  Disclaimer491

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Seasonal Allergic Rhinitis - Pipeline Review, H2 2016" Aug 17, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Seasonal-Allergic-Rhinitis-Pipeline-Review-H2-2016-2088-16391>
  
APA:
Global Markets Direct - Market Research. (2016). Seasonal Allergic Rhinitis - Pipeline Review, H2 2016 Aug 17, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Seasonal-Allergic-Rhinitis-Pipeline-Review-H2-2016-2088-16391>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.